We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approves Epidiolex to Treat Seizures From Tuberous Sclerosis

The cannabis-derived oral spray can now be prescribed for seizures associated with tuberous sclerosis complex (TCS), a rare genetic condition that causes benign tumors to develop in different parts of the body.

Read More

Nevada Authorities Investigate Three Dispensaries For Selling Contaminated Flower

The Nevada Cannabis Compliance Board has begun investigating three state dispensaries for selling a product that twice failed microbial testing.

Read More

Federal Scientists Launch Hemp Program to Help Standardize Testing Methods

The scientists behind the new initiative at the National Institute of Standards and Technology also plan to help standardize the testing methods used for cannabis products, such as edibles, tinctures, and balms.

Read More

FDA Submits New CBD Policies to White House for Review

If given approval, the new regulations could come into effect in a matter of weeks.

Read More

Hemp Pet Products Recalled Due to High Lead Levels, FDA Announces

A US company is voluntarily recalling a swathe of hemp tincture products, intended for dog, cat, and human consumption, after the Florida Department of Health tested some samples and found dangerous levels of lead.

Read More

Nebraska Approves its First Hemp Testing Lab

Cannabis Testing Laboratories, which received ISO-certification in early July, was later added to Nebraska’s Department of Agriculture’s list of approved hemp testing facilities.

Read More

Rhode Island Licenses its First Medical Cannabis Lab

Up until Green Peaks’ approval, any medical cannabis sold in Rhode Island dispensaries had either been tested by growers, by the dispensaries, or by unlicensed, private labs.

Read More

European Commission Considers Reclassifying CBD as a Narcotic

The review has paused over 50 applications from CBD companies hoping to acquire a “novel food” status for their products.

Read More

CBD in the UK: Predictions for 2021

For all the excitement, the UK’s CBD industry is actually facing a roadblock, writes Professor Mike Barnes.

Read More

Advertisement